REMINDER: Our focusIR Investor Webinar takes place TONIGHT with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIxico Share News (IXI)

Share Price Information for Ixico (IXI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 7.375
Bid: 7.25
Ask: 7.50
Change: 0.00 (0.00%)
Spread: 0.25 (3.448%)
Open: 7.375
High: 7.375
Low: 7.375
Prev. Close: 7.375
IXI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Giulio Cerroni appointed CEO of IXICO

Tue, 17th Jan 2017 08:47

(ShareCast News) - Brain health company IXICO announced on Tuesday that Giulio Cerroni will be appointed to the board as chief executive officer, with effect from 6 February.The AIM-traded firm said Derek Hill, the co-founder and current CEO, will remain on the board and continue to serve as an executive director.It said Hill will have specific responsibility for deepening the company's relationships with major pharmaceutical companies, key opinion leaders and government agencies as well as advancing its range of digital technologies. Cerroni reportedly has almost 30 years of international management experience gained in life sciences and diagnostics sectors.He was previously managing director of the genomics division of LGC Group, where he grew divisional revenues threefold and doubled profits through a combined organic and acquisitive growth strategy into an organisation with 480 staff based in ten locations globally.Between April 2015 and August 2016, he led and integrated three US-based acquisitions, significantly enhancing LGC's position as a leading global genomics tools platform.Previously, Cerroni held a variety of senior roles at Thermo Fisher Scientific, Abgene, Anachem, ICN Biomedicals and Du Pont.He has a BSc from Cardiff University and an MBA from Warwick Business School."We are delighted to welcome Giulio to IXICO where he will work with the executive team to lead the business into its next phase of growth," said non-executive chairman Charles Spicer."Giulio brings extensive experience in both scaling operations to build businesses and supplying sophisticated products and services to the pharmaceutical and research communities."Spicer also acknowledged Hill's contributions and vision that enabled IXICO to establish itself as a leading company focused on applying innovative digital technologies to brain health.Giulio Cerroni added that he is "very excited" to be joining IXICO to lead the company's next stage of growth towards becoming the global leader in digital healthcare technologies for the brain health market."Brain diseases are an area of huge unmet need and provide a significant growth opportunity for IXICO's digital health technology platform."In particular, I believe that our scientific leadership in medical data analysis makes IXICO uniquely placed to become the global partner of choice to the pharmaceutical industry as they integrate digital healthcare technologies as part of their overall product offering."
More News
15 Apr 2024 14:25

Ixico inks supply agreement with Life Molecular Imaging for Neuraceq

(Alliance News) - Ixico PLC on Monday said it has signed a supply agreement with Life Molecular Imaging GmbH, in a deal the company says will complement its "well-established PET imaging services and image data analytics".

Read more
15 Apr 2024 09:31

Ixico inks supply agreement with LMI

(Sharecast News) - Analytics company Ixico has inked a supply agreement with Life Molecular Imaging that will see it supply that latter's Neuraceq Amyloid PET tracer for use in pharma-sponsored clinical trials.

Read more
3 Apr 2024 12:08

IN BRIEF: Ixico inks collaboration with IMEKA Solutions

Ixico PLC - neuroscience focused advanced analytics company - Collaborates with IMEKA Solutions Inc, to provide access to Imeka's suite of services for white matter imaging deployed in Alzheimer's disease and multiple sclerosis clinical trials, amongst other CNS indications. Says Imeka's diffusion MRI algorithms will be made available to Ixico's global biopharma clients.

Read more
13 Mar 2024 12:39

Ixico shares fall 20% as revenue to decline, hit by delays to projects

(Alliance News) - Ixico PLC shares dropped sharply on Wednesday, after it said delays to projects will result in lower annual revenue.

Read more
13 Mar 2024 12:25

Ixico warns on 2024 revenue amid contract delays

(Sharecast News) - Medical imaging analytics company Ixico said in a trading update on Wednesday that, despite ongoing progress in expanding its opportunities pipeline, the first half of 2024 had been marked by extended contracting cycles and delays in securing certain new contracts.

Read more
13 Mar 2024 11:12

AIM WINNERS & LOSERS: Woodbois rises as plots Mozambique exit

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
13 Mar 2024 08:51

LONDON MARKET OPEN: FTSE 100 slips but CAC and DAX hit record highs

(Alliance News) - European equities kicked off Wednesday largely on the front foot, picking up the baton after US stocks resumed an "inexorable march" on Tuesday, after shaking off a hot US inflation reading.

Read more
18 Jan 2024 16:29

UK shareholder meetings calendar - next 7 days

Friday 19 January 
Cardiff Property PLCAGM
Character Group PLCAGM
Focusrite PLCAGM
Substrate Artificial Inteligence SAGM re investment agreement and issue of equity
Monday 22 January 
Highcroft Investments PLCGM re de-listing from LSE and relisting on TISE
Smart Metering Systems PLCGM & court meeting re takeover by funds advised by KKR
Tuesday 23 January 
C4X Discovery Holdings PLCAGM
Marston's PLCAGM
Mitchells & Butlers PLCAGM
Wednesday 24 January 
Henderson Far East Income LtdAGM
Lowland Investment Co PLCAGM
Tracsis PLCAGM
Thursday 25 January 
Alteration Earth PLCAGM
Britvic PLCAGM
Greencore Group PLCAGM
Henderson European Focus Trust PLCAGM
Ixico PLCAGM
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
12 Jan 2024 15:51

Ixico CEO to step down by end of year

(Sharecast News) - Medical imaging analytics company Ixico announced on Friday that its chief executive officer Giulio Cerroni planned to retire from his position, and as a director, by the end of 2024.

Read more
12 Jan 2024 10:16

Ixico CEO Cerroni to retire by end of 2024; starts succession search

(Alliance News) - Ixico PLC on Friday said that Chief Executive Officer Giulio Cerroni will retire from his role by the end of 2024.

Read more
5 Dec 2023 14:31

EARNINGS AND TRADING: Ixico revenue falls, Solid State boosts profit

(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
29 Sep 2023 14:19

EARNINGS AND TRADING: Barkby revenue dips; Ixico hurt by trial delays

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

Read more
29 Sep 2023 13:08

Ixico full-year earnings could slightly exceed forecasts

(Sharecast News) - Advanced medical imaging analytics specialist Ixico said in an update on Friday that its earnings for the financial year would either meet or exceed market predictions, even though it faced a minor revenue shortfall.

Read more
18 Jul 2023 16:55

TRADING UPDATES: Andrada raises GBP7.7 million; Ixico signs contract

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
14 Jun 2023 14:17

Ixico awarded new £2m, four-year contract

(Sharecast News) - Medical imaging and analytics specialist Ixico has been awarded a new contract by an existing client, it announced on Wednesday, to provide imaging services for the extension study of their phase 2b trial for Huntington's disease (HD).

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.